GoodRx Holdings, Inc. — Director's Dealing 2021

Apr 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GoodRx Holdings, Inc. (GDRX)
CIK: 0001809519
Period of Report: 2021-04-22

Reporting Person: Slutsky Andrew (President, Consumer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-22	Class A Common Stock	S	19900	$39.0843	Disposed	3141623	Direct
2021-04-22	Class A Common Stock	S	100	$39.53	Disposed	3141523	Direct
2021-04-23	Class A Common Stock	S	10346	$40.0157	Disposed	237072	Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.52 to $39.51, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3: This Form 4 corrects the total number of shares directly held by the Reporting Person. On April 5, 2021, the Reporting Person filed a Form 4 which reported that, following all transactions reported, the Reporting Person directly held 3,706,359 shares of Class A common stock and such Form 4 should have showed that the Reporting Person held 3,161,523 shares of Class A common stock.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.06, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F5: Shares held by The Arisa Slutsky Spousal Trust.